Description

The EASL Policy Statement on liver cancer screening has recently been updated.

In addition to addressing the updates, this episode of EASL Studio will discuss how risk-based surveillance of hepatocellular carcinoma (HCC) in patients suffering from cirrhosis is a cost effective strategy to increase benefits, reduce the harm of HCC surveillance.

Faculty

• Prof. Thomas Berg (Moderator)
• Mr. Pietro Fiocchi (Faculty)
• Prof. Peter Jepsen (Faculty)
• Mrs. José Willemse (Patient Perspective) 

Listen to the podcast